- Research
- Open access
- Published:
Positive associations between sex hormones, bone metabolism and cognitive impairment in Chinese oldest-old females
BMC Psychiatry volume 23, Article number: 562 (2023)
Abstract
Purpose
With a rapid increase in older adults, progressive impairment in cognitive function has become an increasing concern owing to high social and economic burdens. The current study was designed to investigate the associations of sex hormones and bone metabolism with cognitive impairment (CI) in Chinese oldest-old females.
Methods
There were 396 oldest-old females from the China Hainan Oldest-old Cohort Study (CHOCS). Following standardized procedures, Mini Mental State Examination was effectively completed, and sex hormones and bone metabolism were assessed in these females.
Results
The median age of all females was 101 years (range: from 80 to 116). There were 340 females (86%) with CI. Participants with CI had significantly higher levels of age, progesterone, prolactin and estradiol than those without CI (P < 0.05 for all). Total type I collagen N-terminal elongation peptide [hazard ratio (HR): 1.018, 95%CI: 1.001–1.035] and prolactin (HR: 1.065, 95%CI: 1.005–1.129) levels were positively and significantly associated with CI (P < 0.05 for all).
Conclusions
Prolactin and total type I collagen N-terminal elongation peptide had positive associations with CI in Chinese oldest-old females. Thus, a balance in sex hormones and bone metabolism may have significant effects on cognitive function during the aging process.
Introduction
Aging is associated with an impairment in cognitive function, including verbal and visual memory, executive function, and spatial ability [1]. The number of older people is estimated to increase from 524 million in 2010 to 1.5 billion in 2050 all over the world [2]. Approximately 4.6 million people are diagnosed with dementia each year, with a 2-fold increase in the disease prevalence every 20 years [3]. Therefore, with a rapid increase in older adults, progressive impairment in cognitive function has become an increasing concern owing to high social and economic burdens [4, 5].
Pre-clinical and clinical studies have demonstrated that older females have a higher prevalence of cognitive impairment (CI), which may be closely connected with sex hormones, especially after menopause [6,7,8]. Approximately 60% women has CI after menopause, and hormonal change plays important effects on cognitive function [9]. There are several hypotheses on the sex differences in CI, such as difference in brain volume, anatomy and metabolism [10, 11]. Furthermore, there are reduced bone mineral density as a result of aging and physical inactivity. Previous study has indicated that CI have significant relationships with bone mineral density and sex hormone levels in older females [12, 13]. The pathophysiology of osteoporosis may be also related to the occurrence of dementia [14]. The estrogen receptor regulator Raloxifene has been used for the treatment of osteoporosis and may have the ability to improve cognitive function [15]. However, the exact relationships between between sex hormones, bone metabolism and CI still have no clear understanding in Chinese oldest-old females.
Hainan Province is an area with high prevalence of longevity; in fact, it has the highest population density of oldest-old females in China. Oldest-old females may represent a prototype of human longevity and should be considered the best representative [16]. The China Hainan Oldest-old Cohort Study (CHOCS) provides a considerable population-based sample of oldest-old females [17, 18]. For the first time, the current study was designed to investigate the associations of sex hormones and bone metabolism with CI in Chinese oldest-old females. It was hypothesized that CI may be related to sex hormones and bone metabolism in this population.
Methods
According to the list of oldest-old adults provided by the Department of Civil Affairs of Hainan Province, household survey was conducted on 1863 participants in 18 cities and counties from June 2014 to December 2016. Inclusion criteria: (1) aged ≥ 80 years; (2) residing in Hainan province. Exclusion criteria: (1) male adults; (2) did not complete Mini-Mental State Examination (MMSE) and had missing sex hormones and bone metabolism. Finally, there were 396 oldest-old females aged ≥ 80 years included in this study. The current study was performed in accordance with the principles stated in the Declaration of Helsinki and received the approval from Ethics Committee of Hainan Hospital of Chinese People’s Liberation Army General Hospital (Sanya, Hainan; Number: 301HNLL-2016-01). Informed consent was obtained from all subjects and their legal guardians.
Following standardized procedures, the household survey method was used to collect basic information with interview questionnaires, physical examinations, and blood tests conducted by professional doctors and nurses who could communicate in the local language. No participants received vitamin D, exogenous steroids, or other treatments that could affect their sex hormones and bone metabolism. The primary indicator was MMSE. It is well known that cognitive function was measured using the MMSE [19]. The Georgia Centenarian Study has confirmed that education significantly affect the performance of MMSE [20]. The cutoff points for identifying CI had definite distinction for people who had different levels of education: illiteracy with 17 points, elementary school level with 20 points, and junior high school level with 24 points were identified as CI [21, 22].
Blood samples were collected and transported by trained nurses in chilled bio-transport container (4 °C) to our Central Laboratory within 4 h. Plasma levels of sex hormones and bone metabolism were analyzed with the enzymatic analyses (Roche Products Ltd, Basel, Switzerland) on a fully automatic biochemical autoanalyzer (Cobas c702; Roche Products Ltd, Basel, Switzerland). All analyses were carried out by qualified technicians who were blinded to clinical data.
Statistical analyses
Data were analyzed using the Statistical Package for Social Sciences Version 17 (Chicago, IL, USA). Data were described using means and standard deviations (continuous variables with normal distribution), medians and interquartile ranges (continuous variables with skewed distribution), and numbers and percentages (categorical variables). Characteristic comparison was performed between participants with and without CI using Student’s t-tests for continuous variables with normal distribution, Mann–Whitney U tests for continuous variables with skewed distribution, and Chi-square tests for categorical variables. Logistic regression analysis was applied to analyze the factors associated with CI adjusted by all variables in Table 1 except MMSE and education level. A two-tailed P < 0.05 was regarded as statistically significant.
Results
The median age of all females was 101 years (range: from 80 to 116). There were 340 females (86%) with CI. Table 1 showed characteristic comparison between all participants with and without CI. Participants with CI had significantly higher levels of age, progesterone, prolactin and estradiol than those without CI (P < 0.05 for all). As shown in Table 2, total type I collagen N-terminal elongation peptide [hazard ratio (HR): 1.018, 95%CI: 1.001–1.035] and prolactin (HR: 1.065, 95%CI: 1.005–1.129) levels were positively and significantly associated with CI (P < 0.05 for all).
Discussion
The current study provided epidemiological evidence that prolactin and total type I collagen N-terminal elongation peptide levels were positively and significantly associated with CI in Chinese oldest-old females. All the above results give us a clue that an impairment in cognitive function of oldest-old females may be contributed by the change in sex hormones and bone metabolism.
Sex hormones play important roles in the brain of ovariectomized rodent, suggesting that menopause causes the changed levels of circulating sex hormones, which may have a certain effect on the occurrence of dementia. The current results showed that prolactin levels were positively and significantly associated with CI in Chinese oldest-old females. The Henderson recent review has indicated similar results that prolactin may have deleterious effects on cognitive function in older females after menopause [23]. One large study of women not taking hormone therapy showed significant relationships of prolactin with both verbal memory and global cognition [24]. Besides, a cohort study of Japanese-American women has realized that the users of prolactin showed an impairment in cognitive function [25, 26]. However, prolactin have been reported to play protective effects on pathogenic or brain dysfunction in various cell and animal models, such as different stroke types, traumatic brain injury, and age-related neurodegenerative diseases [27,28,29]. In a word, there exists definite associations between CI and prolactin, but they are very complex, especially in postmenopausal oldest-old females.
Bone has been established as an endocrine organ regulating energetic metabolism, insulin secretion, and cognitive function [30,31,32,33]. Bone metabolism has been identified to affect cognitive function [30]. Besides, low bone mineral density is related to CI in community-dwelling adults [34]. Recent studies have confirmed that circulating biomarkers of bone metabolism may have clinical potential to predict worsening CI [35, 36]. It is well known that bone formation is represented by total type I collagen n-terminal elongation peptide. The current study found that total type I collagen n-terminal elongation peptide levels were positively and significantly associated with CI, suggesting that CI may have positive association with bone resorption. Thus, an improvement in bone health may have beneficial effects on cognitive function during the aging process [37, 38].
Over the past 20–30 years, issues related to aging, multimorbidity, and poly pharmacy have become a prominent problem in healthcare worldwide [39]. In a retrospective study of patients older than 65 years admitted from a home care facility, 66% used five or more medications, 46% used more than seven medications, and 21% used 10 or more medications [40]. The number of drugs per prescription and their age are susceptibility factors for drug drug interaction (DDI) and potential adverse reactions (ADR). The prevalence of DDI and ADR in older adults has been reported to be two to three times greater than that in younger ones [41]. Therefore, poly pharmacy may also contribute to an increase in prolactin levels. An increased risk in older adults may be related to impaired organ reserve capacity, common multiple organ dysfunction, and altered pharmacokinetics and pharmacodynamics [42].
The new contribution of this study was that the study population was very representative. In the long-lived oldest-old females in Hainan Island of China, prolactin and total type I collagen N-terminal elongation peptide were found to have positive associations with CI, which provides scientific basis for cognitive aging prevention and brain health care of older women. However, this study has one limitation: it is a cross-sectional study. No causal relationship can be determined by this study.
Conclusions
The current study demonstrated that prolactin and total type I collagen N-terminal elongation peptide had positive associations with CI. Thus, a balance in sex hormones and bone metabolism may have significant effects on cognitive function during the aging process.
Availability of data and material
All data and material are available under the requirement to the corresponding authors.
Abbreviations
- CI:
-
cognitive impairment
- CHOCS:
-
China Hainan Oldest-old Cohort Study
- HR:
-
hazard ratio
- MMSE:
-
Mini-Mental State Examination.
References
Price L, Said K, Haaland KY. Age-associated memory impairment of logical memory and visual reproduction. J Clin Exp Neuropsychol. 2004;26(4):531–8.
Tarry-Adkins JL, Ozanne SE. Nutrition in early life and age-associated diseases. Ageing Res Rev. 2017;39:96–105.
Yaffe K, Browner W, Cauley J, et al. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc. 1999;47:1176–82.
Blazer DG, Yaffe K, Karlawish J. Cognitive aging: a report from the Institute of Medicine. JAMA. 2015;313(21):2121–2.
Barnes LL, Bennett DA. Alzheimer’s disease in African Americans: risk factors and challenges for the future. Health Aff. 2014;33(4):580–6.
Dye RV, Miller KJ, Singer EJ et al. Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis. 2012;258454.
Phung TK, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord. 2010;30:43–50.
Koolschijn PC, Crone EA. Sex differences and structural brain maturation from childhood to early adulthood. Dev Cogn Neurosci. 2013;5:106–18.
Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2001;14(2):252–61.
Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19:197–209.
Carter CL, Resnick EM, Mallampalli M, et al. Sex and gender differences in Alzheimer’s disease: recommendations for future research. J Womens Health. 2012;21:1018–23.
Zhou R, Deng J, Zhang M, et al. Association between bone mineral density and the risk of Alzheimer’s disease. J Alzheimers Dis. 2011;24:101–8.
Schrager S. Epidemiology of osteoporosis in women with cognitive impairment. Ment Retard. 2006;44:203–11.
Laudisio A, Fontana DO, Rivera C, et al. Bone mineral density and cognitive decline in elderly women: results from the InCHIANTI Study. Calcif Tissue Int. 2016;98(5):479–88.
Yang ZD, Yu J, Zhang Q. Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials. Maturitas. 2013;75:341–8.
Fu S, Yu H, Li Y, et al. Multiple measures of mineral metabolism were associated with renal function in chinese centenarians: a cross-sectional study. Front Med. 2020;7:120.
Fu S, Yao Y, Lv F, et al. Associations of immunological factors with metabolic syndrome and its characteristic elements in chinese centenarians. J Transl Med. 2018;16(1):315.
Fu S, Hu J, Chen X, et al. Mutant single nucleotide polymorphism rs189037 in ataxia-telangiectasia mutated gene is significantly associated with ventricular wall thickness and human lifespan. Front Cardiovasc Med. 2021;8:658908.
Ibrahim NM, Shohaimi S, Chong HT, et al. Validation study of the mini-mental state examination in a malay-speaking elderly population in Malaysia. Dement Geriatr Cogn Disord. 2009;27:247e53.
Xiu S, Zheng Z, Guan S, et al. Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing. Neurosci Lett. 2017;637:182e7.
Rabins P, Schwartz S, Tschanz JA, et al. Risk factors for severe dementia from a population-based sample of incident Alzheimer’s disease: the Cache County Dementia Progression Study. Alzheimers Dement. 2011;7:356.
Kliegel M, Zimprich D, Rott C. Life-long intellectual activities mediate the predictive effect of early education on cognitive impairment in centenarians: a retrospective study. Aging Ment Health. 2004;8:430e7.
Henderson WV. Progesterone and human cognition. Climacteric. 2018;21(4):333–40.
Henderson VW, St. John JA, Hodis HN, et al. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A. 2013;110:20290–5.
Rice MM, Graves AB, McCurry SM, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older japanese american women: the Kame Project. Arch Intern Med. 2000;160:1641–9.
de Wit H, Schmitt L, Purdy R, et al. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology. 2001;26:697–710.
Jiang N, Chopp M, Stein D, et al. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 1996;735:101–7.
Roof RL, Hoffman SW, Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol. 1997;31:1–11.
Wali B, Sayeed I, Stein DG. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci. 2011;29:61–71.
Obri A, Khrimian L, Karsenty G, et al. Osteocalcin in the brain: from embryonic development to age-related decline in cognition. Nat Reviews Endocrinol. 2018;14(3):174.
Oury F, Khrimian L, Denny CA, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 2013;155:228–41.
Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–69.
Ferron M, Hinoi E, Karsenty G, et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA. 2008;105:5266–70.
Kang HG, Park HY, Ryu HU, et al. Bone mineral loss and cognitive impairment: the PRESENT Project. Medicine. 2018;97(41):e12755.
Ross RD, Shah RC, Leurgans S, et al. Circulating Dkk1 and TRAIL are associated with cognitive decline in community-dwelling older adults with cognitive concerns. J Gerontol A Biol Sci Med Sci. 2018;73(12):1688–94.
Lui LY, Stone K, Cauley JA, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51:38–43.
Bradburn S, McPhee JS, Bagley L, et al. Association between osteocalcin and cognitive performance in healthy older adults. Age Ageing. 2016;45:844–9.
Hsu CL, Nagamatsu LS, Davis JC, et al. Examining the relationship between specific cognitive processes and falls risk in older adults: a systematic review. Osteoporos Int. 2012;23:2409–24.
Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA. Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia. J Adv Pharm Technol Res. 2013;4(4):183–9.
Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55(10):M554–9.
Nolan L, O’Malley K. Prescribing for the elderly. Part 1: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;36:142–49.
Gaeta T, Fiorini M, Ender K, Bove J, Diaz J. Potential drug-drug interactions in elderly patients presenting with syncope. J Emerg Med. 2002;2:159–62.
Acknowledgements
We appreciate all the staff of CHCCS for their continued cooperation and contribution in field work.
Funding
This work was supported by grants from the Excellent Youth Incubation Program of Chinese People’s Liberation Army General Hospital (2020-YQPY-007), 2021 Military Training Injury Prevention Treatment Research Task (21xls37), the Natural Science Foundation of Hainan Province (821QN389, 821MS112, 822MS193, 822MS198, 820MS126, 820QN383), the Military Medical Science and Technology Youth Incubation Program (20QNPY110, 19QNP060), the Sanya Medical and Health Science and Technology Innovation Project (2016YW21, 2018YW10, 2018YW11), the National Key R&D Program of China (2018YFC2000400), the National S&T Resource Sharing Service Platform Project of China (YCZYPT[2018]07), the Specific Research Fund of Innovation Platform for Academicians of Hainan Province (YSPTZX202216), the Traditional Chinese Medicine Service Capacity Cultivating Program (2021ZY053), the Heatstroke Treatment and Research Center of PLA (413EGZ1D10), the Simulation Training for Treatment of Heat Stroke, and the Major Science and Technology Programme of Hainan Province (ZDKJ2019012). The sponsors had no role in the design, conduct, interpretation, review, approval or control of this article. The sponsors had no role in the design, conduct, interpretation, review, approval or control of this article.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study design, conducted the data collection and analyses, and drafted the paper. All authors have read and approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The current study was performed in accordance with the principles stated in the Declaration of Helsinki and received the approval from Ethics Committee of Hainan Hospital of Chinese People’s Liberation Army General Hospital (Sanya, Hainan; Number: 301HNLL-2016-01). Informed consent was obtained from all subjects and their legal guardians.
Consent for publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Feng, L., Bian, L., Ning, C. et al. Positive associations between sex hormones, bone metabolism and cognitive impairment in Chinese oldest-old females. BMC Psychiatry 23, 562 (2023). https://doi.org/10.1186/s12888-023-04957-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12888-023-04957-9